Northwell Health extends partnership with comprehensive Allscripts Sunrise™ platform through 2027

CHICAGO–(BUSINESS WIRE)–Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced that Northwell Health has extended its engagement with the comprehensive Allscripts Sunrise inpatient platform through December 2027. Sunrise is currently in use at 19 Northwell hospitals.

Northwell Health—New York State’s largest health system, which has been live on Sunrise since 2005—continues to expand the platform’s use as additional Northwell Health facilities come on board. The health system previously extended its Allscripts TouchWorks® EHR agreement in 2018.

The power of Sunrise drives our system across nearly 20 locations, helping our organization deliver on our mission of improving the health of our communities,” says Northwell CIO John Bosco. “Running successfully on one instance of the EHR proves especially beneficial for ensuring our thousands of clinicians can easily access consistent and comprehensive patient clinical information.”

Used by healthcare organizations across the globe, Sunrise is an integrated electronic health record that connects all aspects of care, including acute, ambulatory, surgical, pharmacy, radiology and laboratory services. Built to enable efficient and safe care, Sunrise is a clinician-friendly, evidence-based single platform with integrated analytics that helps deliver true personalized care. Sunrise supports all core care venues across the enterprise by delivering a single patient record, and features patient-centric capabilities that increase access and convenience.

Allscripts partnership with our largest client, Northwell Health, has been a great success for the past 15 years. We are honored to continue pursuing our shared vision with such a brilliant thought leader in our industry,” said Allscripts CEO Paul Black. “Northwell is truly passionate about advancing its community’s health. Side by side we will continue to enhance Sunrise and co-develop the next generation of EHR as a new powerful solution, a tool for clinicians not only at Northwell but at other providers and for those they serve. It’s an honor to extend our partnership with Northwell and its visionary leadership.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Contacts

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Tom Lynch

312-386-6765

Tom.Lynch@allscripts.com

Staff

Recent Posts

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

2 minutes ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

2 minutes ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

1 hour ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

3 hours ago